Role of ATP-sensitive K+ channels in cGMP-mediated pial artery vasodilation

Role of ATP-sensitive K+ channels in cGMP-mediated pial artery vasodilation
复制标题

DOI:
10.1152/ajpheart.1996.270.2.h423
复制
发表时间:
1996-02-01
影响因子:
4.8
通讯作者:
Armstead, WM
Armstead, WM
中科院分区:
医学2区
文献类型:
--
作者:
Armstead, WM

文献摘要

被引文献

相似文献

本研究旨在探讨atp敏感的K+通道在鸟苷3',5'-环单磷酸酯(cGMP)介导的新生猪颅窗关闭时动脉血管舒张中的作用。硝普钠(SNP) (10(-8), 10(-6) M)是一种硝基血管扩张剂,可引起冠状动脉扩张,并被atp敏感的K+通道拮抗剂格列本脲(10(-6)M)减弱。在百分比基础上,SNP (10(-6) M)单独存在时,这些反应为25 +/- 1%,而格列本脲存在时,SNP (10(-6) M)的反应为15 +/- 1% (n = 5头猪)。cGMP类似物8-BrcGMP (10(-8), 10(-6) M)产生的扩张同样被格列本脲减弱。snp诱导的心梗扩张伴随着皮质蛛网膜周围脑脊液(CSF) cGMP水平的升高,这些生化变化被可溶性鸟苷酸环化酶抑制剂LY-83583 (10(-5) M)阻断。单独的SNP (10(-6) M)使CSF cGMP浓度从407 +/- 14增加到956 +/- 41 fmol/ml,而LY-83583存在的SNP使CSF cGMP浓度为340 +/- 13,与对照组的335 +/- 23 fmol/ml (n = 5头猪)没有差异。snp诱导的心梗扩张被LY-83583减弱,而8- brcgmp诱导的心梗扩张没有变化。Cromakalim (10(-8), 10(-6) M)是一种atp敏感的K+通道激动剂,在格列本脲不存在和不存在的情况下,Cromakalim (10(- 6) M)产生的扩张被格列本脲阻断(分别为24 +/- 1比5 +/- 1%,n = 5)。这些数据表明atp敏感的K+通道的激活有助于cgmp介导的头动脉扩张。
The present study was designed to investigate the role of ATP-sensitive K+ channels in guanosine 3',5'-cyclic monophosphate (cGMP)-mediated pial artery vasodilation in newborn pigs equipped with a closed cranial window. Sodium nitroprusside (SNP) (10(-8), 10(-6) M), a nitrovasodilator, elicited pial artery dilation that was attenuated by the ATP-sensitive K+ channel antagonist glibenclamide (10(-6) M). On a percentage basis, these responses were 25 +/- 1% for the presence of SNP (10(-6) M) alone, whereas 15 +/- 1% dilation was observed for SNP (10(-6) M) in the presence of glibenclamide (n = 5 pigs). Dilation produced by the cGMP analogue, 8-BrcGMP (10(-8), 10(-6) M), was similarly attenuated by glibenclamide. SNP-induced pial dilation was accompanied by increased cortical periarachnoid cerebrospinal fluid (CSF) cGMP levels, and these biochemical changes were blocked by the soluble guanylate cyclase inhibitor, LY-83583 (10(-5) M). SNP (10(-6) M) alone increased CSF cGMP concentration from 407 +/- 14 to 956 +/- 41 fmol/ml, whereas SNP in the presence of LY-83583 yielded a CSF cGMP concentration of 340 +/- 13, which was no different from the control value of 335 +/- 23 fmol/ml (n = 5 pigs). SNP-induced pial dilation was blunted by LY-83583, whereas 8-BrcGMP-induced dilation was unchanged. Cromakalim (10(-8), 10(-6) M), an ATP-sensitive K+ channel agonist, produced dilation that was blocked by glibenclamide (24 +/- 1 vs. 5 +/- 1% for cromakalim 10(-6) M, in the absence and presence of glibenclamide, respectively, n = 5). These data indicate that activation of ATP-sensitive K+ channels contribute to cGMP-mediated pial artery dilation.